Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 358,476
  • Shares Outstanding, K 113,084
  • Annual Sales, $ 5,720 K
  • Annual Income, $ -110,570 K
  • 60-Month Beta 2.20
  • Price/Sales 62.89
  • Price/Cash Flow N/A
  • Price/Book 1.50
Trade ABSI with:

Options Overview Details

View History
  • Implied Volatility 139.64% ( -99.77%)
  • Historical Volatility 96.14%
  • IV Percentile 58%
  • IV Rank 8.08%
  • IV High 1,112.13% on 10/12/23
  • IV Low 54.18% on 09/06/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 1,317
  • Volume Avg (30-Day) 407
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 18,560
  • Open Int (30-Day) 18,121

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 4
  • High Estimate -0.17
  • Low Estimate -0.24
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +29.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.80 +18.07%
on 06/20/24
5.20 -36.54%
on 06/13/24
-1.08 (-24.66%)
since 06/07/24
3-Month
2.80 +18.07%
on 06/20/24
6.72 -50.89%
on 04/09/24
-2.34 (-41.49%)
since 04/08/24
52-Week
1.11 +197.00%
on 10/26/23
6.72 -50.89%
on 04/09/24
+1.86 (+129.17%)
since 07/07/23

Most Recent Stories

More News
3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...

NVDA : 128.20 (+1.88%)
GOOGL : 189.03 (-0.82%)
AMZN : 199.29 (-0.36%)
GS : 464.82 (+0.02%)
ABCL : 2.75 (+2.23%)
REGN : 1,052.25 (+1.74%)
MRNA : 116.45 (-1.58%)
LLY : 918.00 (+0.38%)
NVS : 108.06 (-0.06%)
SDGR : 21.19 (+2.32%)
BMY : 39.99 (+0.83%)
ABSI : 3.30 (+4.10%)
Absci Reports Second Quarter 2022 Financial Results and Business Update

Exceeded annual Active Program guidance with ten programs signed year-to-date Executed strategic reorganization to extend cash runway into late-2025 ...

ABSI : 3.30 (+4.10%)
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference

VANCOUVER, Wash. and NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 3.30 (+4.10%)
Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event

VANCOUVER, Wash. and NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 3.30 (+4.10%)
Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires

VANCOUVER, Wash. and NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 3.30 (+4.10%)
Absci Enters Multi-Program Collaboration with Emerging Biotech Partner

Seven program deal with stealth-mode ADC company to leverage Absci’s Bionic Protein™ technology...

ABSI : 3.30 (+4.10%)
Absci Reports First Quarter 2022 Financial and Operating Results

VANCOUVER, Wash., May 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI...

ABSI : 3.30 (+4.10%)
Absci Reports Full Year 2021 Financial and Operating Results

VANCOUVER, Wash., March 22, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI...

ABSI : 3.30 (+4.10%)
Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA

Absci to present in-silico drug discovery technology at NVIDIA GTC Breakthrough ML achievements highlight the viability of the computational lead...

ABSI : 3.30 (+4.10%)
Absci Appoints Dr. Andreas Busch to Board of Directors

Dr. Busch brings deep operational expertise in drug discovery to Absci’s Board...

ABSI : 3.30 (+4.10%)

Business Summary

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single...

See More

Key Turning Points

3rd Resistance Point 4.06
2nd Resistance Point 3.88
1st Resistance Point 3.59
Last Price 3.30
1st Support Level 3.12
2nd Support Level 2.94
3rd Support Level 2.65

See More

52-Week High 6.72
Fibonacci 61.8% 4.58
Fibonacci 50% 3.92
Last Price 3.30
Fibonacci 38.2% 3.25
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar